Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1977 1
1991 1
1994 3
1995 2
1996 1
1999 4
2000 4
2001 2
2002 8
2003 3
2004 3
2005 10
2006 13
2007 10
2008 18
2009 12
2010 26
2011 32
2012 39
2013 55
2014 53
2015 67
2016 56
2017 59
2018 82
2019 88
2020 86
2021 122
2022 99
2023 112
2024 100
2025 101

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,118 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A. Morris PG, et al. J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101038 Free PMC article. Clinical Trial.

Median overall survival (OS) was not reached (median follow-up for survivors, 5.9 years); 3-year OS was 87%. The overall (N = 52) median PFS was 3.3 years, and median OS was 6.6 years. Cognitive assessment showed improvement in executive function (P < .01) and verbal me

…
Median overall survival (OS) was not reached (median follow-up for survivors, 5.9 years); 3-year OS was 87%. The overall (N = 52) med …
Expression of Concern.
[No authors listed] [No authors listed] Addict Biol. 2024 Sep;29(9):e13437. doi: 10.1111/adb.13437. Addict Biol. 2024. PMID: 40179057 Free PMC article.
A. Ghaderi, H.R. Banafshe, N. Mirhosseini, M, Motmaen, F. Mehrzad, F. Bahmani, E. Aghadavod, M.A. Mansournia, R.J. Reiter, M-A. Karimi, and Z. Asemi, "The Effects of Melatonin Supplementation on Mental Health, Metabolic and Genetic Profiles in Patients Under Methado …
A. Ghaderi, H.R. Banafshe, N. Mirhosseini, M, Motmaen, F. Mehrzad, F. Bahmani, E. Aghadavod, M.A. Mansournia, R.J. Reiter, M-A. Ka …
Effects of dynamic neuromuscular stabilization (DNS) training on functional movements.
Mahdieh L, Zolaktaf V, Karimi MT. Mahdieh L, et al. Hum Mov Sci. 2020 Apr;70:102568. doi: 10.1016/j.humov.2019.102568. Epub 2020 Jan 13. Hum Mov Sci. 2020. PMID: 31950895 Clinical Trial.
Repeated Measures ANOVA showed a significant interaction in all five FMs tests in favour of DNS group (F((1,32)) 4.13, P .001 and n(2) 0.29), meaning that DNS group had a higher progress rate compared to that of PF group. ...
Repeated Measures ANOVA showed a significant interaction in all five FMs tests in favour of DNS group (F((1,32)) 4.13, P .001 and n(2 …
Spatial landscape of the tumor immune microenvironment.
Chen Y, Liu Y, Han L. Chen Y, et al. Trends Cancer. 2023 Jun;9(6):459-460. doi: 10.1016/j.trecan.2023.03.006. Epub 2023 Mar 25. Trends Cancer. 2023. PMID: 36967255
Two recent studies published in Nature by Karimi et al. and Sorin et al. applied multiplexed imaging mass cytometry (IMC) to characterize the single-cell tumor immune landscapes covering millions of cells in brain tumors and lung adenocarcinomas (LUAD). ...
Two recent studies published in Nature by Karimi et al. and Sorin et al. applied multiplexed imaging mass cytometry (IMC) to characte …
Staff-Care by Chaplains during COVID-19.
Tata B, Nuzum D, Murphy K, Karimi L, Cadge W. Tata B, et al. J Pastoral Care Counsel. 2021 Apr;75(1_suppl):24-29. doi: 10.1177/1542305020988844. J Pastoral Care Counsel. 2021. PMID: 33730921 Free PMC article.
The researchers analyzed data collected from an International Survey of Chaplain Activity and Experience during Covid-19 (N = 1657). The findings revealed positive changes that emerged and new practices evolved around the use of technology as useful tools for maintaining c …
The researchers analyzed data collected from an International Survey of Chaplain Activity and Experience during Covid-19 (N = 1657). …
Molecular features of T and N stage progression in laryngeal cancer.
Li N, Zeng PYF, Kim HAJ, Karimi A, Ying S, Shaikh MH, Khan H, Joris K, Al Jawhri M, Cecchini M, Mymryk JS, Barrett JW, Nichols AC. Li N, et al. Oral Oncol. 2025 Jun;165:107283. doi: 10.1016/j.oraloncology.2025.107283. Epub 2025 Apr 15. Oral Oncol. 2025. PMID: 40239580 Free article.
Using data from The Cancer Genome Atlas (TCGA), we analyzed 112 patient LSCC samples, comparing patient proteome, transcriptome and genome between early and late T and N samples. We observed significant differences in SNV frequency for various genes between the early and l …
Using data from The Cancer Genome Atlas (TCGA), we analyzed 112 patient LSCC samples, comparing patient proteome, transcriptome and genome b …
Nigella sativa (black seed) safety: an overview.
Mashayekhi-Sardoo H, Rezaee R, Karimi G. Mashayekhi-Sardoo H, et al. Asian Biomed (Res Rev News). 2020 Sep 20;14(4):127-137. doi: 10.1515/abm-2020-0020. eCollection 2020 Aug. Asian Biomed (Res Rev News). 2020. PMID: 37551386 Free PMC article. Review.
LD(50) for administered N. sativa seed fixed oil varied from 28.8 mL/kg to 3,371 mg/kg in mice, while 21 g/kg of aqueous, methanol, and chloroform extracts of N. sativa did not lead to any mortality. Subacute toxicity evaluations indicated that aqueous, methanol, an …
LD(50) for administered N. sativa seed fixed oil varied from 28.8 mL/kg to 3,371 mg/kg in mice, while 21 g/kg of aqueous, methanol, a …
Frequency of Registered Cases of Multiple Sclerosis.
Karimi S, Derakhshan M, Tondro A. Karimi S, et al. Maedica (Bucur). 2023 Jun;18(2):216-221. doi: 10.26574/maedica.2023.18.2.216. Maedica (Bucur). 2023. PMID: 37588820 Free PMC article.
Among all MS participants, the ratio of female to male participants was 1.5:1, and 52.14% (n=747) of all studied patients were persons aged over 60 years. Discussion and conclusion:Based on our findings and patients' data provided by the center of special diseases of Kerma …
Among all MS participants, the ratio of female to male participants was 1.5:1, and 52.14% (n=747) of all studied patients were person …
1,118 results